University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more ...

The FDA approved Edwards Lifesciences Corp.'s Sapien 3 platform for patients with asymptomatic severe aortic stenosis.

As the degree of stenosis becomes worse ... Since this percentage increases substantially in aortic stenosis, the loss of the atrial kick with atrial fibrillation can significantly compromise ...

Doctors at New York-Presbyterian performed an extremely rare surgery on Hend Almesafri, 10, John Catoliato, 2, and Teddy Carter, 3, changing their lives forever.

Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.

Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.

Early transcatheter aortic valve replacement (TAVR) in asymptomatic severe aortic stenosis reduces the risk of death, stroke, and heart failure hospitalization compared to clinical surveillance.

FDA Approves SAPIEN 3 Platform for Asymptomatic Severe Aortic Stenosis By Lori Solomon HealthDay ReporterMONDAY, May 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...